

QUICK LINKS
NVP-BHG712 treatment leads to the inhibition of RTK auto-phosphorylation in stable transfected A375 melanoma cells with EC50 of 25 nM and 4.2 μM for EphB4 and VEGFR2, respectively.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
NVP-BHG712, 5 mg | sc-364554 | 5 mg | $232.00 | |||
NVP-BHG712, 50 mg | sc-364554A | 50 mg | $1764.00 |